[Periodic hypokalemic paralysis caused by high endogenous catecholamine activity?].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004837:Epinephrine / Q000502:physiology*; D006801:Humans; D006947:Hyperkalemia / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D007328:Insulin / Q000502:physiology*; D010243:Paralysis / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics
D000319:Adrenergic beta-Antagonists; D007328:Insulin; D004837:Epinephrine
Periodische hypokaliämische Lähmung durch hohe endogene Katecholaminaktivität?